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A highly purified rat liver protein kinase phosphorylates and inactivates acetyl-CoA carboxylase, and causes 
rapid inactivation of microsomal HMG-CoA reductase in the presence of MgATP. Both effects are stimu- 
lated in an identical manner by AMP, and are greatly reduced by prior treatment ofthe kinase with purified 
protein phosphatase. The dephosphorylated kinase can be reactivated in the presence ofMgATP, apparent- 
ly due to a distinct kinase kinase, and this reactivation is stimulated by nanomolar concentrations of palmi- 
toyl-CoA. These results show that a common, bicyclic protein kinase cascade can potently inactivate the 
regulatory enzymes of both fatty acid and cholesterol biosynthesis. 
Protein kinase; Acetyl-CoA carboxylase; Hydroxymethylglutaryl-CoA reductase; Fatty acid synthesis; 
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1. INTRODUCTION 
Cholesterol and fatty acids in mammals are 
derived either from the diet, or from de novo syn- 
thesis via branching pathways which diverge from 
a common pool of cytoplasmic acetyl-CoA. There 
are several situations in which the two biosynthetic 
pathways are regulated in parallel. They exhibit a 
synchronous diurnal rhythm in rat liver [1,2], a 
finding which may be explained by diurnal varia- 
tion in the insulin/glucagon ratio, since insulin 
stimulates and glucagon inhibits both pathways in 
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isolated rat hepatocytes [3,4]. The peak diurnal 
rates of both pathways are also reduced by 
60-70% when rats are fed a diet high in polyun- 
saturated fatty acids [5]. 
The important sites of regulation within the 
pathways of fatty acid and cholesterol synthesis 
are believed to be those catalyzed by acetyl-CoA 
carboxylase and HMG-CoA reductase, respective- 
ly, and both enzymes are known to be regulated by 
reversible phosphorylation. Acetyl-CoA carbox- 
ylase is phosphorylated at multiple sites by a varie- 
ty of protein kinases, some of which inactivate the 
enzyme [6-lo]. These protein kinases include a 
cyclic AMP-independent protein kinase which we 
have recently partially purified from rat liver [ 1 l] 
and which we have tentatively termed acetyl-CoA 
carboxylase kinase-3 (ACK3). HMG-CoA reduc- 
tase is also inactivated by multiple protein kinases 
[ 121, including a protein kinase which is stimulated 
by phosphorylation [ 13,141, and an AMP- 
stimulated protein kinase [15,16]. It has not been 
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clear whether these latter two HMG-CoA reduc- 
tase kinases are distinct enzymes. 
We now present evidence that ACKS, and the 
HMG-CoA reductase kinase activities that are 
stimulated by phosphorylation and by AMP, are 
all functions of the same protein. This bicyclic 
phosphorylation cascade allows the potential for 
coordinate regulation of fatty acid and cholesterol 
synthesis, two pathways which compete for a com- 
mon precursor. 
2. MATERIALS AND METHODS 
2.1. Materials 
ACK3 was purified from a 10000 x g superna- 
tant fraction of rat liver in the presence of 5 mM 
Na pyrophosphate and 50 mM NaF as described 
[ll], except with the addition of a DEAE- 
Sepharose chromatography step prior to the 
phosphocellulose chromatography. The kinase was 
purified approx. 700-lOOO-fold to a final specific 
activity of 30-50 units/mg: details of the purifica- 
tion will be published elsewhere. Rat liver 
microsomes were prepared as described in [17]. 
HMG-CoA reductase-overproducing hamster cells 
(UT-l cells) were grown in roller bottles in 40 PM 
compactin [18]. They were homogenized in a 
Dounce homogenizer at 4°C in hypotonic buffer 
(10 mM Tris/HCl, pH 7.5, 1 mM EDTA, 5 mM 
EGTA, 10 mM DTT, 0.25% (v/v) DMSO, 
50sg/ml leupeptin, 1 mM PMSF), and 2 M 
sucrose (1: 7 by volume) was then added to make 
the medium isotonic. Membranes were collected by 
centrifugation (100000 x g, 60 min, 4”C), washed 
twice by resuspension and recentrifugation in 
100 mM Na Hepes, pH 7.0, 250 mM NaCl, 1 mM 
EDTA, 5 mM EGTA, 5 mM DTT, 0.25% DMSO, 
50pg/ml leupeptin and 1 mM PMSF, and stored 
in aliquots at -70°C. The specific activity of 
HMG-CoA reductase in these membrane prepara- 
tions was -120 units/mg. Sources of other 
materials have been described elsewhere [9, IO]. 
of 50~1. After incubation for 10 min at 3O”C, in- 
corporation of phosphate into protein was 
measured by trichloroacetic acid precipitation [9]. 
1 unit of ACK3 incorporates 1 nmol of phosphate 
into acetyl-CoA carboxylase per min at 30°C. 
Acetyl-CoA carboxylase was assayed as described 
in [ 191. HMG-CoA reductase kinase activity was 
assayed by incubating UT-l cell membranes 
(0.92 mg protein/ml) and kinase in Na Hepes, pH 
7.2 (80 mM), NaCl (100 mM), EDTA (0.2 mM), 
EGTA (1 n&I), DTT (1 mM), DMSO (0.1 Yo), 
leupeptin (2OOpg/ml), PMSF (0.2 mM), MgCl2 
(5 mM), ATP (0.2 mM). After incubation for 
5 min at 0°C 20~1 aliquots were removed for 
spectrophotometric assay of HMG-CoA reductase 
]201* 
2.3. Dephosphorylationknactivation and re- 
activation of ACK3 
For the experiments hown in figs 2A and 4B, 
ACK3 was incubated at 30°C in 50 mM Na Hepes, 
pH 7.0, 10% (w/v) glycerol, 100 mM NaCl, 
2.5 mM NaF, 1 mM EDTA, 1 mM DTT with or 
without the purified catalytic subunit of protein 
phosphatase-2A (20 U/ml). At various times ali- 
quots were withdrawn and diluted in the same buf- 
fer containing 50 mM NaF. An equivalent amount 
of phosphatase-2A was added to controls after in- 
cubation to preclude the possibility that any 
fluoride-resistant phosphatase activity could in- 
terfere in the .kinase assays. 
For the reactivation experiments (fig.2B), ACK3 
was purified as far as the DEAE-Sepharose step 
and was dialyzed into buffer without NaF or 
pyrophosphate (50 mM Na Hepes, pH 7.0, 10% 
(w/v) glycerol, 1 mM EDTA, 1 mM DTT, 0.02% 
Brij 35). The specific activity of these preparations 
was around 0.5 U/mg. It was then incubated at 
30°C at 4.8 mg/ml in the same buffer containing 
30 mM NaF with or without palmitoyl-CoA and 
0.2 mM ATP/S mM Mg acetate. 
2.2. Enzyme assays 
3. RESULTS 
ACK3 was assayed in incubations containing 3.1. Reversible phosphorylation and inactivation 
acetyl-CoA carboxylase (0.48 mg/ml) and AMP of acetyl-CoA carboxylase by ACK3 
(200/1M) in Na Hepes, pH 7.0 (40 mM), glycerol ACK3 has been purified 700-lOOO-fold from the 
(5%, v/v), NaCl(80 mM), EDTA (0.8 mM), DTT post-mitochondrial supernatant of rat liver using 
(0.8 mM), Mg acetate (5 mM) and [T-~~P]ATP six purification steps. As reported [ 111, it 
(0.2 mM, l-2 x lo5 cpm/nmol) in a final volume phosphorylates purified rat acetyl-CoA carbox- 
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ylase to a stoichiometry exceeding 1 mol/mol 
240 kDa subunit. This is associated with -75% in- 
activation (fig. 1) when acetyl-CoA carboxylase is 
assayed at near-saturating citrate concentration 
(10 mM), and >95% inactivation at a more 
physiological citrate concentration (0.5 mM) [ 1 I]. 
These effects were completely reversed by 
dephosphorylation with protein phosphatase-2A 
(fig. 1). 
3.2. Regulation of acetyl-CoA carboxylase 
kinase-3 by phosphorylation and by AMP 
We obtained clear evidence that ACK3 is itself 
regulated by phosphorylation, i.e. that this is a 
‘bicyclic’ protein phosphorylation system. 
Purification of ACK3 was carried out in the 
presence of the protein phosphatase inhibitor, 
sodium fluoride, and if this was omitted the activi- 
ty was very labile. Fig.2A shows that enzyme 
prepared in the presence of fluoride was rapidly in- 
activated in the presence of the purified catalytic 
subunit of protein phosphatase-2A. Fig.2B shows 
that a time-dependent reactivation of the kinase 
occurred when a partially purified preparation, 
which had been inactivated by dialysis in the 
absence of fluoride, was incubated with MgATP. 
I I I 1 
5 IO 15 
Time (min) 
Fig.2. (A) Inactivation of ACK3 by protein 
phosphatase3A; (B) MgATP-dependent reactivation of 
dephosphorylated ACK3 in the presence and absence of 
20 40 60 80 
Time (min) 
Fig.1. Effect of successive treatment with (1) ACK3 
(0.03 units/ml) plus MgATP and (2) protein 
phosphatase-2A (20 U/ml) on the phosphorylation (0) 
and activity (m) of purified acetyl-CoA carboxylase 
(0.7 mg/ml). The protein phosphatase was added at the 
point shown by the arrow together with EDTA (10 mM 
final) to block the kinase reaction. The activity is plotted 
as a percentage of the activity in control incubations 
lacking ACK3, while the phosphorylation is corrected 
for slight phosphorylation (< 0.1 mol/subunit) which 
This MgATP-dependent reactivation did not occur 
with more highly purified preparations, suggesting 
that the partially purified kinase was reactivated by 
a contaminating ‘kinase kinase’ rather than by 
autophosphorylation. Intriguingly, we found in 
three independent preparations that the reactiva- 
tion of ACK3 by endogenous kinase kinase was 
stimulated 2-4-fold by palmitoyl-CoA in the range 
of 50-200 nM (e.g. fig.2B). Palmitoyl-CoA had 
no effect when the preincubation was carried out 
in the absence of MgATP (not shown), confirming 
that it affected the kinase kinase reaction, and not 
the ACK3 reaction. 
occurred in the absence of ACK3. 
In previous work in which crude preparations of 
acetyl-CoA carboxylase from rat liver were in- 
cubated with MgATP, Yeh et al. [21] reported that 
inactivation of acetyl-CoA carboxylase was 
stimulated by AMP. The phosphorylation of 
acetyl-CoA carboxylase by ACK3 was stimulated 
4-fold by AMP with a half-maximal effect at 
-2 PM (fig.3A). 
November 
- phosphatase 
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+ phosphatase 
. 
l 
I I I 
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Time (min) 
200 nM palmitoyl-CoA. 
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Fig.3. Activation of the acetyl-CoA carboxylase kinase (A) and HMG-CoA reductase kinase (B) activities of the enzyme 
preparation by AMP. Results are expressed relative to results of incubations without AMP. 
3.3. Inactivation of HMG-CoA reductase by 
purified acetyl-CoA carboxylase kinase-3 
Two of the properties of ACK3, i.e. stimulation 
by micromolar concentrations of AMP, and ac- 
tivation/inactivation by kinase kinaseiprotein 
phosphatase, have been reported previously for 
protein kinase activities which regulate HMG-CoA 
reductase, the regulatory enzyme of cholesterol 
synthesis [ 12-161. To investigate the possibility 
that ACK3 might be related to one or both of these 
HMG-CoA reductase kinases, we studied the ef- 
fect of ACK3 on HMG-CoA reductase activity in 
membranes prepared from UT-l cells, a hamster 
cell line which overexpresses HMG-CoA reductase 
[18]. Fig.4A shows that highly purified ACK3 
rapidly inactivates HMG-CoA reductase in a UT- 1 
cell membrane fraction. Rapid inactivation was 
Time (min) 
dependent on the addition of both ACK3 and 
MgATP, although there was a slow inactivation in 
the presence of MgATP alone, due apparently to 
UT-l cell HMG-CoA reductase kinase present in 
the membranes. Similar results were obtained us- 
ing rat liver microsomes in place of UT-l cell mem- 
branes (not shown). Fig.4B shows that the 
inactivation of the UT-l cell enzyme was markedly 
reduced by prior treatment of ACK3 with protein 
phosphatase, while fig.3B shows that it was 
stimulated 3-4-fold by AMP with a half-maximal 
effect at -3 PM. 
4. DISCUSSION 
Our results show that a highly purified prepara- 
tion of a rat liver protein kinase, which 
0 
Time (min) 
Fig.4. Time course of inactivation of HMG-CoA reductase by ACK3. (A) Using untreated ACK3 (1.7 units/ml). 
Controls lacked either ATP or ACK3. (B) Using ACK3 (0.9 units/ml) which had been pretreated with or without protein 
phosphatase-2A for 20 min, and expressing results as percentages of the HMG-CoA reductase activities in control 
incubations lacking ACK3. 
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phosphorylates and inactivates acetyl-CoA carbox- 
ylase, also rapidly and potently inactivates HMG- 
CoA reductase in a time-dependent manner in the 
presence of MgATP. That these effects are func- 
tions of the same protein is shown by the observa- 
tions that both phosphorylation of acetyl-CoA 
carboxylase and inactivation of HMG-CoA reduc- 
tase were stimulated in an identical manner by 
micromolar concentrations of AMP, and were 
reduced markedly when the protein kinase 
preparation had been previously treated with pro- 
tein phosphatase. In addition, we have recently 
shown that the acetyl-CoA carboxylase kinase and 
HMG-CoA reductase kinase activities copurify 
from the crude post-mitochondrial supernatant (in 
preparation). Our results also suggest that the 
HMG-CoA reductase kinase activities which are 
activated by AMP and by phosphorylation are the 
same enzyme, a point that has not been clear from 
previous studies [ 13- 161. 
This bicyclic protein kinase system clearly has 
the potential to regulate coordinately fatty acid 
and cholesterol biosynthesis in rat liver. Although 
further experiments are necessary to prove that 
ACK3 phosphorylates both HMG-CoA reductase 
and acetyl-CoA carboxylase in vivo, several 
testable hypotheses can be framed regarding the 
function of this bicyclic phosphorylation system. 
The system may allow minute-by-minute modula- 
tion of the two pathways in response to hormones, 
and there is already evidence in rat hepatocytes 
that both enzymes are phosphorylated in response 
to glucagon [3,19]. Activation of the protein 
kinase by AMP could cause inhibition of these 
ATP- and NADPH-consuming pathways in cells 
depleted of ATP, e.g. by anoxia. Another function 
of the system may be feedback regulation, since it 
has been shown that phosphorylation of HMG- 
CoA reductase occurs in response to cholesterol 
feeding in vivo [22], while our results show that 
palmitoyl-CoA, the end-product of fatty acid syn- 
thesis, activates the phosphorylation cascade in 
vitro. Simultaneous inactivation of HMG-CoA 
reductase, via the common kinase system, would 
prevent acetyl-CoA (accumulated as a result of in- 
hibition of acetyl-CoA carboxylase) from being 
diverted into cholesterol synthesis [23]. 
It is important to note that the existence of a 
common regulatory protein kinase does not imply 
that changes in the rate of fatty acid and 
cholesterol synthesis will always occur coordinate- 
ly in vivo. Both enzymes are also regulated in- 
dependently at the level of protein synthesis 
and/or degradation [12,241, and this is particularly 
important for HMG-CoA reductase, for which the 
half-life can be as low as 2-4 h [25]. It is also 
possible that phosphorylation of the two enzymes 
by this kinase system could be modulated in- 
dependently by binding of effecters to the protein 
substrates. There is evidence that sterols interact 
with the membrane domain of HMG-CoA reduc- 
tase [25] and this could conceivably promote 
phosphorylation of this enzyme [22] without af- 
fecting acetyl-CoA carboxylase. 
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